Clinical trial
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and…
NCT00002755 · Scottish Cancer Therapy Network, Other · Completed
Key facts
| NCT number | NCT00002755 |
|---|---|
| Title | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer |
| Official title | PROSPECTIVE RANDOMISED EVALUATION OF HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR SUPPORT IN PATIENTS WITH HIGH RISK BREAST CANCER |
| Lead sponsor | Scottish Cancer Therapy Network, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, CMF regimen, cyclophosphamide, doxorubicin hydrochloride, fluorouracil, methotrexate, tamoxifen citrate, thiotepa, autologous bone marrow transplantation, peripheral blood stem cell transplantation and 3 more |
| Enrollment | 600 |
| Start date | Nov 1, 1995 |
| Completion | Jun 1, 1999 |
| First posted | Aug 24, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: